Biohaven Pharma (BHVN) and Pfizer (PFE) announce strategic collaboration for the global commercialization of NURTEC ODT outside the United States
Go back to Biohaven Pharma (BHVN) and Pfizer (PFE) announce strategic collaboration for the global commercialization of NURTEC ODT outside the United States| (NYSE: BHVN) | Delayed: 15.18 -0.32 (2.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.50 | 52 Week High | $ | |||
| Open | $15.15 | 52 Week Low | $ | |||
| Day High | $15.80 | P/E | N/A | |||
| Day Low | $15.04 | EPS | $ | |||
| Volume | 344,686 | |||||
| (NASDAQ: PRTG) | Delayed: 6.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.81 | 52 Week High | $ | |||
| Open | $6.81 | 52 Week Low | $ | |||
| Day High | $6.81 | P/E | N/A | |||
| Day Low | $6.81 | EPS | $ | |||
| Volume | 2,270 | |||||

